ABIONYX Pharma SA (EPA:ABNX)
France flag France · Delayed Price · Currency is EUR
1.954
-0.038 (-1.91%)
Aug 21, 2026, 5:35 PM CET

ABIONYX Pharma Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
6913441414868
Market Cap Growth
5.78%223.58%-0.54%-14.37%-28.38%178.53%
Enterprise Value
6913439444963
Last Close Price
1.953.731.171.271.702.41

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-9.449.449.449.449.44
PS Ratio
16.9732.869.078.949.23100.22
PB Ratio
15.2829.595.495.246.766.34
P/TBV Ratio
--20.0216.8328.2212.95

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
17.0433.058.609.459.3193.31

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.840.840.370.430.560.46
Net Debt / Equity Ratio
0.060.06-0.06-0.090.00-0.28
Net Debt / EBITDA Ratio
-0.05-0.050.110.220.010.51
Net Debt / FCF Ratio
-0.09-0.090.130.190.010.43
Asset Turnover
0.310.310.320.300.280.04
Inventory Turnover
15.1515.1517.1621.8628.49-
Quick Ratio
0.990.991.491.681.391.86
Current Ratio
1.061.061.581.751.491.93
Return on Equity (ROE)
-92.29%-92.29%-56.76%-46.62%-47.14%-67.28%
Return on Assets (ROA)
-25.97%-25.97%-19.67%-13.91%-13.64%-23.16%
Return on Invested Capital (ROIC)
-115.47%-93.60%-62.69%-47.57%-55.39%-228.97%
Return on Capital Employed (ROCE)
-69.60%-69.60%-45.40%-31.30%-38.30%-39.50%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-8.05%-4.16%-10.62%-8.48%-8.68%-8.61%
FCF Yield
-4.60%-2.38%-8.97%-9.16%-7.27%-10.14%
Buyback Yield / Dilution
-3.73%-3.73%-14.80%-4.95%-12.41%-5.92%